GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Shelter Pharma Ltd
Shelter Pharma Appoints Vinita Gadhvi as Independent Director
MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 31 Jul 2026, 11:32 AM IST  ·  BSE ID: b71db874-4876-4f41-ab1a-66bc353e1b9d
View Original BSE Filing (PDF)
💡
In Simple Terms
Shelter Pharma's board has added a new independent director, Ms. Vinita Gadhvi, for a five-year term.
🤖 AI Summary
  • Shelter Pharma appointed Ms. Vinita Gadhvi as an Additional Independent Director.
  • Her tenure is for five consecutive years, commencing July 31, 2026.
  • The appointment is subject to shareholder approval and she will not retire by rotation.
  • Ms. Gadhvi is not related to any current director or Key Managerial Personnel.
  • She is not debarred from holding a director's office by any SEBI or other authority.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders for this appointment, as it is subject to their subsequent approval.
👤
Who Is Affected
All shareholders are affected by this governance enhancement, as the board composition is being strengthened.
🔍
Management Signal
This decision signals management's commitment to good corporate governance and board diversity.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Shareholder meeting notice for director approval.
Disclosure of Ms. Gadhvi's background details.
Future board meeting minutes and decisions.
LOW RISK Standard board appointment, no new risks identified in the filing.
💡 Investor Takeaway
Shelter Pharma has appointed Ms. Vinita Gadhvi as an Additional Independent Director for a five-year term, effective July 31, 2026. Her appointment is subject to shareholder approval.
❓ Frequently Asked Questions
Who has Shelter Pharma appointed as a new director?
Shelter Pharma has appointed Ms. Vinita Shivraj Gadhvi as an Additional Independent Director.
When is Ms. Vinita Gadhvi's appointment effective?
Ms. Vinita Gadhvi's appointment is effective from July 31, 2026, for a tenure of five consecutive years.
Is Ms. Vinita Gadhvi related to any Shelter Pharma directors?
No, Ms. Vinita Gadhvi is not related to any Director or Key Managerial Personnel on the Board of Shelter Pharma.
What is the DIN of Ms. Vinita Gadhvi?
The Director Identification Number (DIN) for Ms. Vinita Shivraj Gadhvi is 09102407.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.